Safety and Pharmacokinetics of an Intramuscular Monoclonal Antibody (SB 209763) Against Respiratory Syncytial Virus (RSV) in Infants and Young Children at Risk for Severe RSV Disease

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.43.5.1183